$0.2325
-0.0027-1.15%
Last update: Oct 26, 9:29 AM
20/20 Biolabs Inc (AIDX) Stock Price, Quote, News & History
AIDXNASDAQ
Shares of Super Micro Computer Inc (NASDAQ: SMCI) rose after reporting record backlog of $60B+ in orders and expected $11-12.5B in Q4 revenue. Gainers include...
You can purchase shares of 20/20 Biolabs (NASDAQ:AIDX) through any online brokerage.
Other companies in 20/20 Biolabs’s space includes: Alcon Inc (NYSE:ALC), Medline Inc (NASDAQ:MDLN), Solventum Corp (NYSE:SOLV), The Cooper Companies Inc (NASDAQ:COO) and Align Technology Inc (NASDAQ:ALGN).
20/20 Biolabs has a consensus price target of $5.00.
The stock price for 20/20 Biolabs (NASDAQ: AIDX) is $0.2351 last updated October 26, 2026 at 9:29 AM EDT.
There are no upcoming dividends for 20/20 Biolabs.
20/20 Biolabs does not have any upcoming earnings scheduled.
There is no upcoming split for 20/20 Biolabs.
20/20 Biolabs is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and...
